NASDAQ:NSPR
InspireMD, Inc.
InspireMD, Inc.'s revenue grew 28.1% in fiscal 2025 to $9.0M while operating margin fell to −552.6%, its lowest in 10 years. Free cash flow was −$36.8M, −409.5% of revenue, and the diluted share count rose 53.4%.Summary generated from InspireMD, Inc.'s SEC filings. Latest annual report filed Mar 18, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$9.0M
Revenue growth+28.1%
Revenue, 5-yr CAGR+29.3%
Gross margin29.5%
Operating margin−552.6%
Net margin−543.3%
ROICn/a
Return on equity−106.9%
Debt / equityn/a
Free cash flow−$36.8M
FCF margin−409.5%
Share count change+53.4%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 | 5 | 6 | 7 | 9 |
| Operating income | −15 | −19 | −21 | −34 | −50 |
| Net income | −15 | −18 | −20 | −32 | −49 |
| Free cash flow | −14 | −16 | −17 | −23 | −37 |
Recent filings
- 4Insider transaction report
Sep 23, 2026 - 4Insider transaction report
Sep 23, 2026 - 8-KEntry into a material agreement
Sep 21, 2026 - 8-KResults of operations and financial condition
Aug 17, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 14, 2026 - 8-KDirector or officer change
Jul 29, 2026 - 8-KNotice of delisting or listing-rule failure
Jul 23, 2026 - 8-KDirector or officer change
Jul 2, 2026